Adjuvant interferon in high-risk melanoma: end of the era?
Janku
Filip
F
Kurzrock
Razelle
R
D017024:Chemotherapy, Adjuvant; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008545:Melanoma / Q000188:drug therapy* / Q000523:psychology; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011788:Quality of Life; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000523:psychology
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b